|
1
|
Molina JR, Yang P, Cassivi SD, Schild SE
and Adjei AA: Non-small cell lung cancer: Epidemiology, risk
factors, treatment, and survivorship. Mayo Clin Proc. 83:584–594.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lamanna AC and Karbstein K: Nob1 binds the
single-stranded cleavage site D at the 3′-end of 18S rRNA with its
PIN domain. Proc Natl Acad Sci USA. 106:14259–14264. 2009.
View Article : Google Scholar
|
|
3
|
Liu K, Chen HL, Gu MM and You QS:
Relationship between NOB1 expression and prognosis of resected
non-small cell lung cancer. Int J Biol Markers. 30:e43–e48. 2015.
View Article : Google Scholar
|
|
4
|
Liu K, Gu MM, Chen HL and You QS: NOB1 in
non-small-cell lung cancer: Expression profile and clinical
significance. Pathol Oncol Res. 20:461–466. 2014. View Article : Google Scholar
|
|
5
|
Kiburu IN and LaRonde-LeBlanc N:
Interaction of Rio1 kinase with toyocamycin reveals a
conformational switch that controls oligomeric state and catalytic
activity. PLoS One. 7:e373712012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Darnell JC; Molecular biology: Ribosome
rescue and neurodegeneration. Science. 345:378–379. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Turowski TW, Lebaron S, Zhang E, Peil L,
Dudnakova T, Petfalski E, Granneman S, Rappsilber J and Tollervey
D: Rio1 mediates ATP-dependent final maturation of 40S ribosomal
subunits. Nucleic Acids Res. 42:12189–12199. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu K, Chen HL, Wang S, Gu MM, Chen XM,
Zhang SL, Yu KJ and You QS: High Expression of RIOK2 and NOB1
Predict human non-small cell lung cancer outcomes. Sci Rep.
6:286662016. View Article : Google Scholar :
|
|
9
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar
|
|
10
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar
|
|
11
|
Shenouda SK and Alahari SK: MicroRNA
function in cancer: Oncogene or a tumor suppressor? Cancer
Metastasis Rev. 28:369–378. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gao Y, Zhang Z, Li K, Gong L, Yang Q,
Huang X, Hong C, Ding M and Yang H: Linc-DYNC2H1-4 promotes EMT and
CSC phenotypes by acting as a sponge of miR-145 in pancreatic
cancer cells. Cell Death Dis. 8:e29242017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Goto Y, Kurozumi A, Arai T, Nohata N,
Kojima S, Okato A, Kato M, Yamazaki K, Ishida Y, Naya Y, et al:
Impact of novel miR-145-3p regulatory networks on survival in
patients with castration-resistant prostate cancer. Br J Cancer.
117:409–420. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wei H, Wen-Ming C and Jun-Bo J: Plasma
miR-145 as a novel biomarker for the diagnosis and radiosensitivity
prediction of human cervical cancer. J Int Med Res. 45:1054–1060.
2017. View Article : Google Scholar :
|
|
15
|
Hu CE, Du PZ, Zhang HD and Huang GJ: Long
noncoding RNA CRNDE promotes proliferation of gastric cancer cells
by targeting miR-145. Cell Physiol Biochem. 42:13–21. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Moon S, Kim DK and Kim J:
Apoptosis-related microRNA-145-5p enhances the effects of
pheophorbide a-based photodynamic therapy in oral cancer.
Oncotarget. 8:35184–35192. 2017. View Article : Google Scholar :
|
|
17
|
Sheng N, Tan G, You W, Chen H, Gong J,
Chen D, Zhang H and Wang Z: miR-145 inhibits human colorectal
cancer cell migration and invasion via PAK4-dependent pathway.
Cancer Med. 6:1331–1340. 2017. View Article : Google Scholar :
|
|
18
|
Ding Y, Zhang C, Zhang J, Zhang N, Li T,
Fang J, Zhang Y, Zuo F, Tao Z, Tang S, et al: miR-145 inhibits
proliferation and migration of breast cancer cells by directly or
indirectly regulating TGF-β1 expression. Int J Oncol. 50:1701–1710.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Minami K, Taniguchi K, Sugito N, Kuranaga
Y, Inamoto T, Takahara K, Takai T, Yoshikawa Y, Kiyama S, Akao Y,
et al: miR-145 negatively regulates Warburg effect by silencing
KLF4 and PTBP1 in bladder cancer cells. Oncotarget. 8:33064–33077.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu S, Gao G, Yan D, Chen X, Yao X, Guo S,
Li G and Zhao Y: Effects of miR-145-5p through NRAS on the cell
proliferation, apoptosis, migration, and invasion in melanoma by
inhibiting MAPK and PI3K/AKT pathways. Cancer Med. 6:819–833. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee
DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, et al:
Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic
Acids Res. 33:e1792005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
23
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ansari J, Shackelford RE and El-Osta H:
Epigenetics in non-small cell lung cancer: From basics to
therapeutics. Transl Lung Cancer Res. 5:155–171. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Reid G, Kao SC, Pavlakis N, Brahmbhatt H,
MacDiarmid J, Clarke S, Boyer M and van Zandwijk N: Clinical
development of TargomiRs, a miRNA mimic-based treatment for
patients with recurrent thoracic cancer. Epigenomics. 8:1079–1085.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang Y, Ni J, Zhou G, Yuan J, Ren W, Shan
Y, Tang W, Yu L and Zhao S: Cloning, expression and
characterization of the human NOB1 gene. Mol Biol Rep. 32:185–189.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lin Y, Peng S, Yu H, Teng H and Cui M:
RNAi-mediated downregulation of NOB1 suppresses the growth and
colony-formation ability of human ovarian cancer cells. Med Oncol.
29:311–317. 2012. View Article : Google Scholar
|
|
28
|
Lu Z, Guo Q, Shi A, Xie F and Lu Q:
Downregulation of NIN/RPN12 binding protein inhibit the growth of
human hepatocellular carcinoma cells. Mol Biol Rep. 39:501–507.
2012. View Article : Google Scholar
|
|
29
|
Li XY, Luo QF, Li J, Wei CK, Kong XJ,
Zhang JF and Fang L: Clinical significance of NOB1 expression in
breast infiltrating ductal carcinoma. Int J Clin Exp Pathol.
6:2137–2144. 2013.PubMed/NCBI
|
|
30
|
Wang H, Li P and Zhao B: Knockdown of NOB1
expression by RNAi inhibits cellular proliferation and migration in
human gliomas. Gene. 528:146–153. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lin S, Meng W, Zhang W, Liu J, Wang P, Xue
S and Chen G: Expression of the NOB1 gene and its clinical
significance in papillary thyroid carcinoma. J Int Med Res.
41:568–572. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu G, Shen D, Jiao L and Sun Y: Nin one
binding protein expression as a prognostic marker in prostate
carcinoma. Clin Transl Oncol. 16:843–847. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Weinberg F, Reischmann N, Fauth L, Taromi
S, Mastroianni J, Köhler M, Halbach S, Becker AC, Deng N, Schmitz
T, et al: The atypical kinase RIOK1 promotes tumor growth and
invasive behavior. EBioMedicine. 20:79–97. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Dolly SO, Collins DC, Sundar R, Popat S
and Yap TA: Advances in the development of molecularly targeted
agents in non-Small-cell lung cancer. Drugs. 77:813–827. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Meerson A, Traurig M, Ossowski V, Fleming
JM, Mullins M and Baier LJ: Human adipose microRNA-221 is
upregulated in obesity and affects fat metabolism downstream of
leptin and TNF-α. Diabetologia. 56:1971–1979. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Pertschy B, Schneider C, Gnädig M, Schäfer
T, Tollervey D and Hurt E: RNA helicase Prp43 and its co-factor
Pfa1 promote 20 to 18 S rRNA processing catalyzed by the
endonuclease Nob1. J Biol Chem. 284:35079–35091. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ferreira-Cerca S, Sagar V, Schäfer T, Diop
M, Wesseling AM, Lu H, Chai E, Hurt E and LaRonde-LeBlanc N:
ATPase-dependent role of the atypical kinase Rio2 on the evolving
pre-40S ribosomal subunit. Nat Struct Mol Biol. 19:1316–1323. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Woolls HA, Lamanna AC and Karbstein K:
Roles of Dim2 in ribosome assembly. J Biol Chem. 286:2578–2586.
2011. View Article : Google Scholar :
|
|
39
|
Campbell MG and Karbstein K:
Protein-protein interactions within late pre-40S ribosomes. PLoS
One. 6:e161942011. View Article : Google Scholar : PubMed/NCBI
|
